Corpus Intelligence IC Memo — BLUERIDGE VISTA HEALTH & WELNESS 2026-04-26 14:10 UTC
IC Memo — BLUERIDGE VISTA HEALTH & WELNESS
Investment Committee Memorandum | OH | 44 beds | Grade D | EBITDA uplift $835K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BLUERIDGE VISTA HEALTH & WELNESS

CCN 364057 | HAMILTON, OH | 44 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BLUERIDGE VISTA HEALTH & WELNESS is a 44-bed suburban community hospital in HAMILTON, OH with $11.3M in net patient revenue and a 10.8% operating margin. The hospital serves a payer mix of 17.3% Medicare, 1.9% Medicaid, and 80.8% commercial.

Thesis: Turnaround. Our ML models identify $835K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.8% to 18.2% (+740bps).

Net Revenue HCRIS$11.3M
Current EBITDA COMPUTED$1.2M
Operating Margin COMPUTED10.8%
Occupancy HCRIS65.4%
Revenue / Bed COMPUTED$256K
Net-to-Gross HCRIS16.7%
Distress Probability ML43.3%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
116
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 10.8% places it above the state median. Among 116 size-comparable peers (22-88 beds), the median margin is -1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-88), prioritizing same-state peers. 116 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BLUERIDGE VISTA HEALTH & WELNE (Target)OH44$11.3M10.8%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
FISHER-TITUS MEDICAL CENTEROH78$148.3M-6.9%
WESTERN RESERVE HOSPITALOH83$147.6M-9.3%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $835K (740bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$237K+210bp18mo
Cost to Collect4.5%2.5%$226K+200bp12mo
Denial Rate Reduction12.0%6.5%$225K+200bp12mo
A/R Days Reduction5200.0%3800.0%$137K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$237K
Cost to Collect
$226K
Denial Rate Reduction
$225K
A/R Days Reduction
$137K
Clean Claim Rate
$10K
Total EBITDA Uplift$835K
Current EBITDA$1.2M
+ RCM Uplift+$835K
Pro Forma EBITDA$2.1M
Current Margin10.8%
Pro Forma Margin18.2%
WC Released (1x)$433K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.9M$16.4M8.74x54.3%
Base (11x exit)10.0x11.0x$1.9M$18.6M9.94x58.3%
Bull Case9.0x11.0x$1.7M$22.0M13.04x67.1%
Bull (12x exit)9.0x12.0x$1.7M$24.5M14.52x70.8%
Bear Case11.0x10.0x$2.1M$11.6M5.63x41.3%
Bear (11x exit)11.0x11.0x$2.1M$13.4M6.51x45.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 116 hospitals with 22-88 beds
  • Same-state prioritization (n=117)
  • Comp margins: P25=-12.7% / P50=-1.7% / P75=9.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.